ENTITY

Intercept Pharmaceuticals (ICPT US)

27
Analysis
Health CareUnited States
Intercept Pharmaceuticals, Inc. manufactures and markets biopharmaceutical products. The Company focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. Intercept Pharmaceuticals serves customers throughout the United States.
more
x